# Heart in the crossfire, from epsilon to beyond: cardiac sarcoidosis—a case report

**Authors:** Humaid Ali, Hamat Hamdi Che Hassan, Mohd Shawal Faizal Mohamad, Boon Cong Beh

PMC · DOI: 10.1093/ehjcr/ytaf632 · 2025-11-29

## TL;DR

A 66-year-old woman with cardiac sarcoidosis presented with heart failure and arrhythmias, and was diagnosed using a combination of imaging and biopsy findings.

## Contribution

This case report highlights the diagnostic challenges and clinical presentation of cardiac sarcoidosis.

## Key findings

- The patient exhibited symptoms of heart failure and ventricular tachycardia, with inconclusive biopsy results.
- PET scan and CMR findings, along with lymph node biopsy, supported a clinical diagnosis of cardiac sarcoidosis.
- The case illustrates the difficulty in diagnosing cardiac sarcoidosis due to its mimicking of other conditions.

## Abstract

Sarcoidosis is a great mimicker of various medical conditions, which leads to obstacles in early diagnosis and appropriate timely management.

A 66-year-old Indian female with metabolic syndrome was initially treated for decompensated liver disease. Her baseline electrocardiogram showed right bundle branch block with a first-degree heart block. She presented 3 months later with angina and heart failure (HF) symptoms, complicated with ventricular tachycardia (VT) treated with i.v. amiodarone and anti-failure medication. Her coronary angiogram revealed mild disease, and her echocardiography showed a mildly reduced ejection fraction (EF) of 45% with regional wall motion abnormalities. Cardiac magnetic resonance imaging (CMR) revealed non-specific left ventricular (LV) patchy mid-wall to epicardial late gadolinium enhancement. Endomyocardial biopsy was complicated with cardiac tamponade and required pericardiocentesis followed by dual-chamber implantable cardioverter-defibrillator (ICD) later. Unfortunately, biopsy result was inconclusive, and serum angiotensin-converting enzyme was within the normal range. She had multiple admissions for the past 2 years for recurrent VT and decompensated HF despite the optimization of ICD setting and guideline-directed medical therapy. Repeated echocardiogram revealed similar EF with thinning of the LV basal septal segment. Her positron emission tomography (PET) scan (Tc-99 m) showed diffuse uptake at the LV myocardium and supraclavicular/mediastinal/abdominopelvic lymph nodes with a mismatch of fluorodeoxyglucose uptake at the basal–inferolateral segment (non-specific). Lymph node biopsy revealed chronic non-caseating granulomatous inflammation. Clinical diagnosis of cardiac sarcoidosis was made based on a histologic diagnosis of extracardiac sarcoidosis with cardiomyopathy/ventricular arrhythmia combined with PET/CMR findings.

Cardiac sarcoidosis can have a myriad of symptoms, which may mimic several other disorders leading to a diagnostic challenge.

## Linked entities

- **Diseases:** sarcoidosis (MONDO:0008399), heart failure (MONDO:0005252), ventricular tachycardia (MONDO:0005477), metabolic syndrome (MONDO:0000816)

## Full-text entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}
- **Diseases:** angina (MESH:D000787), VT (MESH:D017180), Cardiac sarcoidosis (MESH:D012507), motion (MESH:D009041), cardiomyopathy (MESH:D009202), ventricular arrhythmia (MESH:D001145), right bundle branch block (MESH:D002037), granulomatous inflammation (MESH:D007249), heart block (MESH:D006327), HF (MESH:D006333), liver disease (MESH:D008107), cardiac tamponade (MESH:D002305), metabolic syndrome (MESH:D024821)
- **Chemicals:** amiodarone (MESH:D000638), implantable cardioverter (-), fluorodeoxyglucose (MESH:D019788), Tc-99 m (MESH:D013667)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12813286/full.md

---
Source: https://tomesphere.com/paper/PMC12813286